These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Cellular magnetic resonance imaging: potential for use in assessing aspects of cardiovascular disease. Zhang Z, Mascheri N, Dharmakumar R, Li D. Cytotherapy; 2008 Sep; 10(6):575-86. PubMed ID: 18608350 [Abstract] [Full Text] [Related]
47. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaque. Trivedi R, U-King-Im J, Gillard J. Circulation; 2003 Nov 11; 108(19):e140; author reply e140. PubMed ID: 14610003 [No Abstract] [Full Text] [Related]
48. [[Molecular MR imaging. State of the research with examples describing individual results] ]. Fleige G, Hamm B, Zimmer C. Rofo; 2000 Nov 11; 172(11):865-71. PubMed ID: 11142117 [Abstract] [Full Text] [Related]
49. Labelling dendritic cells with SPIO has implications for their subsequent in vivo migration as assessed with cellular MRI. de Chickera SN, Snir J, Willert C, Rohani R, Foley R, Foster PJ, Dekaban GA. Contrast Media Mol Imaging; 2011 Nov 11; 6(4):314-27. PubMed ID: 21861291 [Abstract] [Full Text] [Related]
50. Flow-enhanced off-resonance saturation for remote detection of iron-based contrast agents. Krämer P, Helluy X, Kampf T, Lang E, Jakob PM. Magn Reson Med; 2010 Jun 11; 63(6):1708-15. PubMed ID: 20512876 [Abstract] [Full Text] [Related]
51. Superparamagnetic Iron Oxide Particles. Gore JC, Majumdar S. Radiology; 1988 Dec 11; 169(3):657-8. PubMed ID: 3186988 [No Abstract] [Full Text] [Related]
52. Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation. Schleich N, Danhier F, Préat V. J Control Release; 2015 Jan 28; 198():35-54. PubMed ID: 25481448 [Abstract] [Full Text] [Related]